Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2019-002960-29Phase 2Completed
Phase 2, randomised, open-label trial of calcipotriol in nail psoriasis and psoriatic disease (2 arms), sponsored by Merete Haedersdal [Bispebjerg Hospital]. Primary endpoint: Change in N-NAIL score per nail. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2019-002960-29.